Hospital News
Return to Prostate Seed Implants Overview
More on Prostate Seed Implants
- Dr. Ashutosh Tewari to Lead New Center for Prostate Cancer at NewYork-Presbyterian/Weill Cornell Medical Center
- September is Prostate Cancer Awareness Month
- Dr. Ashutosh K. Tewari Receives Prestigious Gold Cystoscope Award for Contributions to Field of Urologic Oncology
- Robot Assisted Prostate Cancer Surgery Compares Favorably to Other Surgical Techniques
- NewYork-Presbyterian/Weill Cornell Research Presented at American Urological Association Meeting
- Dr. David C. Madoff Appointed Interventional Radiology Chief at NewYork-Presbyterian/Weill Cornell
- Can a New PET Imaging Technique More Quickly Predict Response to Ongoing Cancer Treatment?
- Laser May Reduce Prostate Surgery's Sexual Side Effects
- NewYork-Presbyterian Hospital/Columbia University Medical Center Physician-Scientists Present at American Urological Association Annual Meeting
- NewYork-Presbyterian Hospital/Weill Cornell Medical Center Physician-Scientists Present at 2010 American Urological Association Meeting
Research and Clinical Trials
Return to Prostate Seed Implants Overview
More on Prostate Seed Implants
Clinical Services
Return to Prostate Seed Implants Overview
More on Prostate Seed Implants
- Advanced Radiation Oncology Technologies
- Brachytherapy
- Brain and Spinal Cord Cancer
- Breast Cancer
- Breast Cancer: Partial Breast Irradiation
- Contact Us / Our Locations
- CT Simulation and Treatment Planning
- Digestive System Cancers
- Find a Clinical Trial
- Gynecological Cancers
- Head and Neck Cancer
- Image-Guided Radiotherapy (IGRT)
- IMRT Symposium
- Intensity-Modulated Radiotherapy (IMRT)
- Lung Cancer
- Other Cancers
- Pediatric Cancers
- Prostate Cancer
- Skin Cancer
- Stereotactic Radiosurgery and Gamma Knife®
- Urology
Radiation Oncology
Prostate Seed Implants
Back to the Radiation Oncology Home Page
Radioactive seeds are sometimes placed in diseased tissue on an outpatient basis or during an operation. They may be used to keep the radiation dose focused on a specific organ or they may be placed in areas where it is difficult or impossible to assure complete surgical removal of all the diseased tissue during an operation. One type of low dose rate brachytherapy is a prostate seed implant or PSI. During this intraoperative procedure, radioactive seeds are placed within the prostate gland to treat prostate cancer. This is one of the most effective options for many men whose cancer is in an early stage. Seeds are placed using ultrasound guided implantation techniques and deliver a dose of radiation to the prostate gland, with real time dose optimization, while sparing the normal surrounding tissues. These tiny seeds contain a radioactive material, such as Iodine-125, Palladium-103 or Cesium-131 and are permanently implanted in the prostate gland where they give off low-level radiation for weeks or months and then become inert.



